GNH USA

Europe — EMA

Miacalcic

GNH USA supplies Miacalcic (Calcitonin), a hormone analog for osteoporosis, Pagets disease of bone and hypercalcemia of malignancy.

Calcitonin

Request sourcing

1
Pack/s

What is Calcitonin?

Calcitonin, the active ingredient in Miacalcic, is a hormone (calcitonin analog) presented as an injectable solution for intramuscular and subcutaneous use. It is employed to manage bone metabolism disorders such as osteoporosis, Pagets disease of bone, and hypercalcemia of malignancy, and to help prevent skeletal complications under medical supervision.

GNH USA supplies Miacalcic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across regions.

What is Calcitonin used for?

Miacalcic (calcitonin) acts on bone metabolism and calcium regulation pathways.

- Osteoporosis: reduces bone resorption and helps maintain bone density. - Pagets disease of bone: normalizes abnormal bone remodeling and lowers elevated alkaline phosphatase. - Hypercalcemia of malignancy: lowers serum calcium by inhibiting osteoclast activity and enhancing renal calcium excretion.

What are the side effects of Calcitonin?

Calcitonin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Flushing: transient warmth and redness of the skin. - Headache: mild to moderate intensity. - Dizziness: occasional light‑headed sensation. - Injection site reactions: pain, erythema, or swelling at the site. - Mild hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: marked blood pressure decline. - Hypocalcemia: clinically significant low serum calcium. - Osteosarcoma: rare malignant bone tumor reported with long‑term use. - Acute allergic reactions: rash, bronchospasm, or angioedema. - Severe injection site necrosis: tissue damage at the injection site.

What precautions apply to Calcitonin?

When using Miacalcic, consider the following precautions.

- Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion; caution advised. - Renal impairment: monitor calcium levels and renal function. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Concomitant calcium supplements: may reduce therapeutic effect. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Calcitonin interact with?

Calcitonin can interact with several medications.

Major Interactions (Avoid): - Calcium supplements: may antagonize calcitonin’s calcium‑lowering effect. - Bisphosphonates: additive reduction of serum calcium can increase hypocalcemia risk. - Loop diuretics: enhance calcium loss, raising hypocalcemia potential.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase renal calcium excretion. - Corticosteroids: can affect bone metabolism and calcium balance. - Thyroid hormones: may alter calcium homeostasis requiring monitoring.

Frequently asked questions

What is Miacalcic used for?+
Miacalcic contains calcitonin and is prescribed to treat conditions related to abnormal bone turnover and high calcium levels, specifically osteoporosis, Pagets disease of bone, and hypercalcemia of malignancy. It helps reduce bone resorption and lower serum calcium, supporting bone health in affected patients.
How does calcitonin work?+
Calcitonin binds to calcitonin receptors on osteoclasts, the cells responsible for breaking down bone. This binding inhibits osteoclast activity, decreasing bone resorption and the release of calcium into the bloodstream. The hormone also promotes renal excretion of calcium, contributing to lower serum calcium concentrations.
What is the usual dose of Miacalcic?+
The dosage of Miacalcic is individualized by the prescribing clinician based on the specific indication, patient characteristics, and clinical response. Healthcare professionals determine the appropriate strength, frequency, and route of administration, and patients should follow the prescriber’s instructions without deviation.
Is Miacalcic safe during pregnancy or breastfeeding?+
Safety data for calcitonin in pregnancy and lactation are limited. The product should only be used if the potential therapeutic benefit justifies any possible risk to the fetus or infant. Clinicians typically weigh the benefits against uncertainties and may consider alternative therapies when possible.
How do I order Miacalcic from GNH USA?+
To request Miacalcic, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.
How does Miacalcic compare with the main alternative drug class?+
The primary alternative for managing bone loss and hypercalcemia is the bisphosphonate class. Bisphosphonates also inhibit osteoclast‑mediated bone resorption but have a different mechanism and longer skeletal retention. Calcitonin offers a rapid, short‑acting effect and can be useful when bisphosphonates are contraindicated or not tolerated.
How should Miacalcic be stored and handled?+
Miacalcic must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. If temporary temperature excursions occur, discard the product to ensure safety and efficacy.
How is Miacalcic administered?+
Miacalcic is supplied as an injectable solution for intramuscular or subcutaneous injection. Administration is performed by a qualified healthcare professional using aseptic technique. The injection site is typically the thigh, upper arm, or abdomen, depending on the chosen route and patient factors.
What are the most serious risks to watch for while using Miacalcic?+
Serious adverse events include severe allergic reactions such as anaphylaxis, marked hypotension, clinically significant hypocalcemia, and, rarely, osteosarcoma with long‑term use. Patients should be instructed to seek immediate medical attention if they experience difficulty breathing, swelling, faintness, or persistent low calcium symptoms.
Who should not use Miacalcic?+
Miacalcic is contraindicated in individuals with known hypersensitivity to calcitonin or any excipients in the formulation. Caution is advised for patients with severe renal impairment, uncontrolled hypocalcemia, or a history of osteosarcoma. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Calcitonin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Essential Pharma (M) Limited
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU